RMD Should I Buy

ResMed Inc. (RMD) is currently not a strong buy for a beginner investor with a long-term strategy. While the company has shown solid financial growth in its latest quarter, the lack of clear technical or proprietary trading signals, coupled with neutral sentiment in hedge fund and insider trading, suggests that waiting for a clearer entry point or more positive catalysts might be prudent. The stock's pre-market price is near a key support level, and analysts have recently downgraded their price targets, reflecting concerns about future growth visibility.

The MACD is slightly positive at 0.43, indicating mild bullish momentum, but it is contracting. RSI is neutral at 44.061, suggesting no clear overbought or oversold conditions. Moving averages are converging, indicating indecision in price direction. The pre-market price of $252.38 is near the S1 support level of $251.542, with resistance at $256.856. Overall, the technical indicators do not provide a strong buy signal.